pubmed-article:1487493 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1487493 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:1487493 | lifeskim:mentions | umls-concept:C0225369 | lld:lifeskim |
pubmed-article:1487493 | lifeskim:mentions | umls-concept:C1184739 | lld:lifeskim |
pubmed-article:1487493 | lifeskim:mentions | umls-concept:C0009339 | lld:lifeskim |
pubmed-article:1487493 | lifeskim:mentions | umls-concept:C0002059 | lld:lifeskim |
pubmed-article:1487493 | lifeskim:mentions | umls-concept:C2246343 | lld:lifeskim |
pubmed-article:1487493 | lifeskim:mentions | umls-concept:C1515100 | lld:lifeskim |
pubmed-article:1487493 | lifeskim:mentions | umls-concept:C1548602 | lld:lifeskim |
pubmed-article:1487493 | pubmed:dateCreated | 1993-2-24 | lld:pubmed |
pubmed-article:1487493 | pubmed:abstractText | The type X collagen is a short chain collagen associated with calcific cartilage and/or the expression of the hypertrophic chondrocyte phenotype. In articular cartilage, type X collagen is restricted to the basal zone of calcified cartilage adjacent to the subchondral bone. However, during pathological change such as in osteoarthritis, the synthesis of type X collagen becomes more widespread but never extends to the articular surface. Using immunocytochemistry and fluorography of newly synthesised collagens, we report that surface articular chondrocytes (which occupy the uppermost 10-15% of the tissue depth) from normal human cartilage initiate de novo synthesis of both type X collagen and alkaline phosphatase when maintained in suspension culture. | lld:pubmed |
pubmed-article:1487493 | pubmed:language | eng | lld:pubmed |
pubmed-article:1487493 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1487493 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1487493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1487493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1487493 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1487493 | pubmed:month | Dec | lld:pubmed |
pubmed-article:1487493 | pubmed:issn | 0021-9533 | lld:pubmed |
pubmed-article:1487493 | pubmed:author | pubmed-author:BaylissM TMT | lld:pubmed |
pubmed-article:1487493 | pubmed:author | pubmed-author:StephensMM | lld:pubmed |
pubmed-article:1487493 | pubmed:author | pubmed-author:ArcherC WCW | lld:pubmed |
pubmed-article:1487493 | pubmed:author | pubmed-author:HUMEJ CJC | lld:pubmed |
pubmed-article:1487493 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1487493 | pubmed:volume | 103 ( Pt 4) | lld:pubmed |
pubmed-article:1487493 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1487493 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1487493 | pubmed:pagination | 1111-6 | lld:pubmed |
pubmed-article:1487493 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:meshHeading | pubmed-meshheading:1487493-... | lld:pubmed |
pubmed-article:1487493 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1487493 | pubmed:articleTitle | Human articular surface chondrocytes initiate alkaline phosphatase and type X collagen synthesis in suspension culture. | lld:pubmed |
pubmed-article:1487493 | pubmed:affiliation | Department of Orthopaedic Surgery, Institute of Orthopaedics (University College and Middlesex School of Medicine), Stanmore, UK. | lld:pubmed |
pubmed-article:1487493 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1487493 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:1487493 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1487493 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1487493 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1487493 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1487493 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1487493 | lld:pubmed |